Nanotherapeutic agent for cancer: Miracle or catastrophe
Open Access
- 28 June 2019
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 3 (1), 010-012
- https://doi.org/10.29328/journal.abse.1001005
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cellsNanomedicine: Nanotechnology, Biology and Medicine, 2015
- Neoantigens in cancer immunotherapyScience, 2015
- Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistanceProceedings of the National Academy of Sciences of the United States of America, 2015
- An Imagable and Photothermal “Abraxane‐Like” Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast TumorsAdvanced Materials, 2014
- Cancer treatment and survivorship statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- New frontiers in nanotechnology for cancer treatmentUrologic Oncology, 2008
- Nanotechnology and CancerAnnual Review of Medicine, 2008
- Application of Nanotechnology in Cancer Therapy and ImagingCA: A Cancer Journal for Clinicians, 2008
- Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug deliveryMolecular Cancer Therapeutics, 2006
- Cancer nanotechnology: opportunities and challengesNature Reviews Cancer, 2005